Stock Report

All about this stock under one free report Last Updated: 09-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Medicenna Therapeutics Corp (MDNA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.31

up-down-arrow $0.00 (0.30%)

As on 03-Jan-2024 09:30EDT

Market cap

info icon

$11 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -19.25 4.15 -14.09 -67.27 -216.81
Net Profit -30.08 -251.89 -6.41 -9.34 -190.08
EPS -30.08 -221.14 14.82 7.82 1.72
Book Value -- -- 13.04 -24.31 36.84
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-23Mar-22
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -38.97-71.37-53.196.15-76.79
Return on Capital info -38.93-71.33--6.15-76.75
Return on Assets info -35.53-48.71-36.595.17-68.93
Debt to Equity (x) info ----0.00----

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
--
6.15
-76.75
-46.19
-42.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-53.19

Lower than Peers by 2.24

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-53.19
6.15
-76.79
-46.26
-42.87
Peer Median
-50.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-36.59

Higher than Peers by 10.25

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-36.59
5.17
-68.93
-42.82
-38.48
Peer Median
-46.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-14.09

Higher than Peers by 22.07

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-14.09
2.95
-29.75
-109.45
-72.88
Peer Median
-36.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-6.41

Higher than Peers by 42.55

Year on year growth in profit after tax

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-6.41
106.83
-31.79
-106.79
-76.49
Peer Median
-48.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

14.82

Higher than Peers by 6.41

Year on year growth in earnings per share

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
14.82
1.05
-0.24
-0.46
-0.36
Peer Median
8.42
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-36.94

Lower than Peers by 177.11

Year on year growth in book value per share

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-36.94
--
--
--
--
Peer Median
140.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
--
--
--
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
--
--
--
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

7.49

Higher than Peers by 1.65

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
7.49
9.58
8.92
10.26
20.85
Peer Median
5.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

7.49

Higher than Peers by 1.65

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
7.49
--
--
--
--
Peer Median
5.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-3.65

Higher than Peers by 24.43

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
-3.65
-1.87
-323.19
--
--
Peer Median
-28.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Medicenna Therapeutics Corp (MDNA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...